# Farmers & Merchants Bancorp: financial statements, quarterly

FMCB · OTC · CIK 1085913 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fmcb.md) · [Financials](/companies/fmcb/financials.md) · [Filings](/companies/fmcb/filings.md) · [Insiders](/companies/fmcb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fmcb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [12.3](/filings/0001140361-23-051422.md) | [13.6 d](/filings/0001140361-24-013280.md) | [14.9](/filings/0001140361-24-025234.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [7.5](/filings/0001140361-24-045878.md) | [7.6 d](/filings/0001140361-26-009383.md) | [8.5](/filings/0001140361-25-018397.md) | [8.4](/filings/0001140361-25-029818.md) | [8.4](/filings/0001140361-25-041120.md) | [8.5 d](/filings/0001140361-26-009383.md) | [9.3](/filings/0001140361-26-020057.md) | [8.3](/filings/0001140361-26-031718.md) | [8.9](/filings/0001140361-25-041120.md) | [8.6 d](/filings/0001140361-26-009383.md) | [8.3](/filings/0001140361-26-020057.md) | [9.0](/filings/0001140361-26-031718.md) |
| Net income | $m | [22.0](/filings/0001140361-24-045878.md) | [21.4 d](/filings/0001140361-26-009383.md) | [22.7](/filings/0001140361-25-018397.md) | [21.8](/filings/0001140361-25-029818.md) | [22.1](/filings/0001140361-25-041120.md) | [21.8 d](/filings/0001140361-26-009383.md) | [23.0](/filings/0001140361-26-020057.md) | [23.1](/filings/0001140361-26-031718.md) | [23.7](/filings/0001140361-25-041120.md) | [23.8 d](/filings/0001140361-26-009383.md) | [24.1](/filings/0001140361-26-020057.md) | [24.7](/filings/0001140361-26-031718.md) |
| Diluted EPS | $ per share | [29.23](/filings/0001140361-24-045878.md) | not reported | [30.56](/filings/0001140361-25-018397.md) | [29.39](/filings/0001140361-25-029818.md) | [29.96](/filings/0001140361-25-041120.md) | not reported | [32.86](/filings/0001140361-26-020057.md) | [32.94](/filings/0001140361-26-031718.md) | [33.92](/filings/0001140361-25-041120.md) | not reported | [35.34](/filings/0001140361-26-020057.md) | [36.39](/filings/0001140361-26-031718.md) |
| Basic EPS | $ per share | [29.23](/filings/0001140361-24-045878.md) | not reported | [30.56](/filings/0001140361-25-018397.md) | [29.39](/filings/0001140361-25-029818.md) | [29.96](/filings/0001140361-25-041120.md) | not reported | [32.88](/filings/0001140361-26-020057.md) | [33.06](/filings/0001140361-26-031718.md) | [34.24](/filings/0001140361-25-041120.md) | not reported | [35.91](/filings/0001140361-26-020057.md) | [36.77](/filings/0001140361-26-031718.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [668](/filings/0001140361-23-051422.md) | [411](/filings/0001140361-25-008871.md) | [738](/filings/0001140361-24-025234.md) | [296](/filings/0001140361-24-036649.md) | [293](/filings/0001140361-24-045878.md) | [213](/filings/0001140361-26-009383.md) | [607](/filings/0001140361-25-018397.md) | [292](/filings/0001140361-25-029818.md) | [173](/filings/0001140361-25-041120.md) | [145](/filings/0001140361-26-031718.md) | [384](/filings/0001140361-26-020057.md) | [279](/filings/0001140361-26-031718.md) |
| Total assets | $m | [5,375](/filings/0001140361-23-051422.md) | [5,309](/filings/0001140361-25-008871.md) | [5,715](/filings/0001140361-24-025234.md) | [5,267](/filings/0001140361-24-036649.md) | [5,418](/filings/0001140361-24-045878.md) | [5,370](/filings/0001140361-26-009383.md) | [5,680](/filings/0001140361-25-018397.md) | [5,479](/filings/0001140361-25-029818.md) | [5,630](/filings/0001140361-25-041120.md) | [5,690](/filings/0001140361-26-031718.md) | [5,837](/filings/0001140361-26-020057.md) | [5,835](/filings/0001140361-26-031718.md) |
| Total liabilities | $m | [4,845](/filings/0001140361-23-051422.md) | [4,759](/filings/0001140361-25-008871.md) | [5,149](/filings/0001140361-24-025234.md) | [4,691](/filings/0001140361-24-036649.md) | [4,815](/filings/0001140361-24-045878.md) | [4,797](/filings/0001140361-26-009383.md) | [5,078](/filings/0001140361-25-018397.md) | [4,860](/filings/0001140361-25-029818.md) | [4,985](/filings/0001140361-25-041120.md) | [5,045](/filings/0001140361-26-031718.md) | [5,181](/filings/0001140361-26-020057.md) | [5,156](/filings/0001140361-26-031718.md) |
| Shareholders' equity | $m | [531](/filings/0001140361-24-045878.md) | [550](/filings/0001140361-26-009383.md) | [565](/filings/0001140361-25-029818.md) | [576](/filings/0001140361-25-041120.md) | [603](/filings/0001140361-25-041120.md) | [573](/filings/0001140361-26-031718.md) | [602](/filings/0001140361-26-031718.md) | [619](/filings/0001140361-26-031718.md) | [645](/filings/0001140361-25-041120.md) | [646](/filings/0001140361-26-031718.md) | [656](/filings/0001140361-26-031718.md) | [679](/filings/0001140361-26-031718.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [28.0 d](/filings/0001140361-24-045878.md) | [(1.0) d](/filings/0001140361-26-009383.md) | [34.8](/filings/0001140361-25-018397.md) | [20.3 d](/filings/0001140361-25-029818.md) | [35.4 d](/filings/0001140361-25-041120.md) | [13.2 d](/filings/0001140361-26-009383.md) | [39.6](/filings/0001140361-26-020057.md) | [21.5 d](/filings/0001140361-26-031718.md) | [29.5 d](/filings/0001140361-25-041120.md) | [13.7 d](/filings/0001140361-26-009383.md) | [40.7](/filings/0001140361-26-020057.md) | [33.0 d](/filings/0001140361-26-031718.md) |
| Capital expenditure | $m | [1.3 d](/filings/0001140361-24-045878.md) | [0.5 d](/filings/0001140361-26-009383.md) | [0.4](/filings/0001140361-25-018397.md) | [0.4 d](/filings/0001140361-25-029818.md) | [0.6 d](/filings/0001140361-25-041120.md) | [1.0 d](/filings/0001140361-26-009383.md) | [0.7](/filings/0001140361-26-020057.md) | [2.6 d](/filings/0001140361-26-031718.md) | [2.1 d](/filings/0001140361-25-041120.md) | [2.2 d](/filings/0001140361-26-009383.md) | [9.5](/filings/0001140361-26-020057.md) | [3.5 d](/filings/0001140361-26-031718.md) |
| Dividends paid | $m | [0.0 d](/filings/0001140361-24-045878.md) | [6.6 d](/filings/0001140361-26-009383.md) | not reported | not reported | [0.0 d](/filings/0001140361-25-041120.md) | [6.5 d](/filings/0001140361-26-009383.md) | [0.0](/filings/0001140361-26-020057.md) | [6.5 d](/filings/0001140361-26-031718.md) | [3.9 d](/filings/0001140361-25-041120.md) | [3.5 d](/filings/0001140361-26-009383.md) | [3.7](/filings/0001140361-26-020057.md) | [3.6 d](/filings/0001140361-26-031718.md) |
| Share repurchases | $m | [2.5 d](/filings/0001140361-24-045878.md) | [4.0 d](/filings/0001140361-26-009383.md) | [5.5](/filings/0001140361-25-018397.md) | [3.5 d](/filings/0001140361-25-029818.md) | [1.3 d](/filings/0001140361-25-041120.md) | [35.1 d](/filings/0001140361-26-009383.md) | [0.7](/filings/0001140361-26-020057.md) | [2.2 d](/filings/0001140361-26-031718.md) | [(0.0) d](/filings/0001140361-25-041120.md) | [0.0 d](/filings/0001140361-26-009383.md) | [0.0](/filings/0001140361-26-020057.md) | [0.0 d](/filings/0001140361-26-031718.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [775](/filings/0001140361-23-051422.md) | [765](/filings/0001140361-24-025234.md) | [760](/filings/0001140361-24-036649.md) | [754](/filings/0001140361-24-045878.md) | [744](/filings/0001140361-25-018397.md) | [741](/filings/0001140361-25-029818.md) | [738](/filings/0001140361-25-041120.md) | [700](/filings/0001140361-26-020057.md) | [700](/filings/0001140361-26-031718.md) | [699](/filings/0001140361-25-041120.md) | [681](/filings/0001140361-26-020057.md) | [680](/filings/0001140361-26-031718.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 691,944 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001140361-26-031718.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.